Related content

Hsp90 inhibitors as novel cancer chemotherapeutic agents

By Neckers L.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite

Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents

By de Vries P.   Singer J.W.  

Experimental Hematology, Vol. 28, Iss. 8, 2000-08 ,pp. : 916-923

Elsevier

Access to resources Recommend Favorite

Hematopoietic stem cells and other hematopoietic cells show broad resistance to chemotherapeutic agents in vivo when overexpressing bcl-2

By Domen J.   Weissman I.L.  

Experimental Hematology, Vol. 31, Iss. 7, 2003-07 ,pp. : 631-639

Elsevier

Access to resources Recommend Favorite

Multiple Target-Specific Molecular Imaging Agents Detect Liver Cancer in a Preclinical Model

By  

Current Molecular Medicine, Vol. 12, Iss. 8, 2012-09 ,pp. : 944-951

Bentham Science Publishers

Access to resources Recommend Favorite

Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in nonsmallcell lung cancer and sensitivity to AZD7451 in vitro

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 725-730

Spandidos Publications

Access to resources Recommend Favorite